202 related articles for article (PubMed ID: 19517779)
61. Determining the technical and clinical factors associated with pain for children undergoing botulinum toxin injections under nitrous oxide and anesthetic cream.
Brochard S; Blajan V; Lempereur M; Garlantezec R; Houx L; Le Moine P; Peudenier S; Lefranc J; Rémy-Néris O
Eur J Paediatr Neurol; 2011 Jul; 15(4):310-5. PubMed ID: 21273098
[TBL] [Abstract][Full Text] [Related]
62. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
63. [Pharmacological management of cerebral palsy--focused on botulinum toxin therapy].
Nezu A; Osawa M
No To Hattatsu; 2008 May; 40(3):241-3. PubMed ID: 18524260
[No Abstract] [Full Text] [Related]
64. [Influence of toxin botulin on walk stereotype of children with juvenile cerebral palsy. The functional examination performed by BTS, comprehensive movement analysis system. A preliminary report].
Kwiecień-Czerwieniec I; Krukowska J; Woldańska-Okońska M
Wiad Lek; 2014; 67(2 Pt 1):59-63. PubMed ID: 25764777
[TBL] [Abstract][Full Text] [Related]
65. Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.
Hoare B
J Child Neurol; 2014 Aug; 29(8):1066-76. PubMed ID: 24820338
[TBL] [Abstract][Full Text] [Related]
66. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
Kang BS; Bang MS; Jung SH
Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
[TBL] [Abstract][Full Text] [Related]
67. Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.
Lott E; Fehlings D; Gelineau-Morel R; Kruer M; Mink JW; Thomas SP; Wisniewski S; Aravamuthan B;
Pediatrics; 2024 Jul; 154(1):. PubMed ID: 38836309
[No Abstract] [Full Text] [Related]
68. Position paper on the use of botulinum toxin in cerebral palsy.
Grice J
Arch Dis Child; 1999 Mar; 80(3):301. PubMed ID: 10325720
[No Abstract] [Full Text] [Related]
69. 'Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?'.
Arens LJ; Goldschmidt RB; Leary PM
Dev Med Child Neurol; 1998 Nov; 40(11):785-7. PubMed ID: 9881811
[No Abstract] [Full Text] [Related]
70. Future needs of young people receiving botulinum toxin A in paediatric rehabilitation services of New South Wales: focus on transition.
Paget SP; de Groot A; Hanns K; Burnett H; Ho J
Intern Med J; 2020 Sep; 50(9):1138-1141. PubMed ID: 32929823
[TBL] [Abstract][Full Text] [Related]
71. The use of diazepam in childhood cerebral palsy. Report of a small study including electromyographic observations.
Holt KS
Ann Phys Med; 1964; Suppl():16-24. PubMed ID: 5317889
[No Abstract] [Full Text] [Related]
72. Botulinum neurotoxin A, blinding, and bias.
Hastings-Ison T; Graham K
Dev Med Child Neurol; 2020 Feb; 62(2):259. PubMed ID: 31225641
[No Abstract] [Full Text] [Related]
73. Some observations on clinical trials with diazepam in cerebral palsy.
Kanjilal GC
Ann Phys Med; 1964; Suppl():30-2. PubMed ID: 5317891
[No Abstract] [Full Text] [Related]
74. Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding.
Copeland L; Edwards P; Sakzewski L; Thorley M; Kentish M; Ware RS; Boyd RN
Dev Med Child Neurol; 2020 Feb; 62(2):260. PubMed ID: 31571206
[No Abstract] [Full Text] [Related]
75. Introduction to the consensus recommendations.
Carruthers J; Fagien S; Matarasso SL;
Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):i-iii. PubMed ID: 15507785
[No Abstract] [Full Text] [Related]
76. Unexpected benefits of bethanechol in adults with cerebral palsy.
Carter WJ
Med J Aust; 2008 Sep; 189(5):293. PubMed ID: 18759732
[No Abstract] [Full Text] [Related]
77. Lanbotulinumtoxin-A: Safe for children with cerebral palsy but is it effective?
Hastings-Ison T; Graham K
Dev Med Child Neurol; 2023 Jan; 65(1):10-11. PubMed ID: 35746861
[TBL] [Abstract][Full Text] [Related]
78. Appraisal of Clinical Practice Guideline: Early intervention for children aged 0 to 2 years with or at high risk of cerebral palsy: International clinical practice guideline based on systematic reviews.
Ilhan E; Johnston LM
J Physiother; 2021 Oct; 67(4):314. PubMed ID: 34511386
[No Abstract] [Full Text] [Related]
79. A baby step for nano.
Tan S
Sci Transl Med; 2012 Apr; 4(130):130fs8. PubMed ID: 22517882
[TBL] [Abstract][Full Text] [Related]
80. Common data elements and minimum data sets in cerebral palsy: Start small to grow big.
Dieterich K
Dev Med Child Neurol; 2022 Dec; 64(12):1433-1434. PubMed ID: 36057943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
